Hepatitis C virus (HCV) nonstructural protein (NS)5A is a RNA-binding protein composed of a N-terminal membrane anchor, a structured domain I (DI) and two intrinsically disordered domains (DII and DIII) interacting with viral and cellular proteins. While DI and DII are essential for RNA replication, DIII is required for assembly. How these processes are orchestrated by NS5A is poorly understood. In this study, we identified a highly conserved basic cluster (BC) at the N-terminus of DIII that is critical for particle assembly. We generated BC mutants and compared them with mutants that are blocked at different stages of the assembly process: a NS5A serine cluster (SC) mutant blocked in NS5A-core interaction and a mutant lacking the envelope glycoproteins (ΔE1E2). We found that BC mutations did not affect core-NS5A interaction, but strongly impaired core–RNA association as well as virus particle envelopment. Moreover, BC mutations impaired RNA-NS5A interaction arguing that the BC might be required for loading of core protein with viral RNA. Interestingly, RNA-core interaction was also reduced with the ΔE1E2 mutant, suggesting that nucleocapsid formation and envelopment are coupled. These findings argue for two NS5A DIII determinants regulating assembly at distinct, but closely linked steps: (i) SC-dependent recruitment of replication complexes to core protein and (ii) BC-dependent RNA genome delivery to core protein, triggering encapsidation that is tightly coupled to particle envelopment. These results provide a striking example how a single viral protein exerts multiple functions to coordinate the steps from RNA replication to the assembly of infectious virus particles.
References
[1]
Bialek SR, Terrault NA. The changing epidemiology and natural history of hepatitis C virus infection. Clinics in liver disease. 2006;10(4):697–715. Epub 2006/12/14. doi: 10.1016/j.cld.2006.08.003 pmid:17164113.
[2]
Lohmann V. Hepatitis C virus RNA replication. Current topics in microbiology and immunology. 2013;369:167–98. Epub 2013/03/07. doi: 10.1007/978-3-642-27340-7_7 pmid:23463201.
[3]
Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science. 1999;285(5424):110–3. Epub 1999/07/03. pmid:10390360. doi: 10.1126/science.285.5424.110
[4]
Pietschmann T, Kaul A, Koutsoudakis G, Shavinskaya A, Kallis S, Steinmann E, et al. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci U S A. 2006;103(19):7408–13. Epub 2006/05/03. doi: 10.1073/pnas.0504877103 pmid:16651538; PubMed Central PMCID: PMC1455439.
[5]
Steinmann E, Penin F, Kallis S, Patel AH, Bartenschlager R, Pietschmann T. Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions. PLoS Pathog. 2007;3(7):e103. Epub 2007/07/31. doi: 10.1371/journal.ppat.0030103 pmid:17658949; PubMed Central PMCID: PMC1924870.
[6]
Jones CT, Murray CL, Eastman DK, Tassello J, Rice CM. Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J Virol. 2007;81(16):8374–83. Epub 2007/06/01. doi: 10.1128/JVI.00690-07 pmid:17537845; PubMed Central PMCID: PMC1951341.
[7]
Romero-Brey I, Merz A, Chiramel A, Lee JY, Chlanda P, Haselman U, et al. Three-dimensional architecture and biogenesis of membrane structures associated with hepatitis C virus replication. PLoS Pathog. 2012;8(12):e1003056. Epub 2012/12/14. doi: 10.1371/journal.ppat.1003056 pmid:23236278; PubMed Central PMCID: PMC3516559.
[8]
Paul D, Hoppe S, Saher G, Krijnse-Locker J, Bartenschlager R. Morphological and biochemical characterization of the membranous hepatitis C virus replication compartment. J Virol. 2013;87(19):10612–27. Epub 2013/07/26. doi: 10.1128/JVI.01370-13 pmid:23885072; PubMed Central PMCID: PMC3807400.
[9]
Miyanari Y, Atsuzawa K, Usuda N, Watashi K, Hishiki T, Zayas M, et al. The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol. 2007;9(9):1089–97. Epub 2007/08/28. doi: 10.1038/ncb1631 pmid:17721513.
[10]
Gastaminza P, Cheng G, Wieland S, Zhong J, Liao W, Chisari FV. Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J Virol. 2008;82(5):2120–9. Epub 2007/12/14. doi: 10.1128/JVI.02053-07 pmid:18077707; PubMed Central PMCID: PMC2258938.
[11]
Bartenschlager R, Penin F, Lohmann V, Andre P. Assembly of infectious hepatitis C virus particles. Trends in microbiology. 2011;19(2):95–103. Epub 2010/12/15. doi: 10.1016/j.tim.2010.11.005 pmid:21146993.
[12]
Andre P, Komurian-Pradel F, Deforges S, Perret M, Berland JL, Sodoyer M, et al. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol. 2002;76(14):6919–28. Epub 2002/06/20. pmid:12072493; PubMed Central PMCID: PMC136313. doi: 10.1128/jvi.76.14.6919-6928.2002
[13]
Cai Z, Zhang C, Chang KS, Jiang J, Ahn BC, Wakita T, et al. Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells. J Virol. 2005;79(22):13963–73. Epub 2005/10/29. doi: 10.1128/JVI.79.22.13963–13973.2005 pmid:16254332; PubMed Central PMCID: PMC1280219.
[14]
Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, et al. Complete replication of hepatitis C virus in cell culture. Science. 2005;309(5734):623–6. Epub 2005/06/11. doi: 10.1126/science.1114016 pmid:15947137.
[15]
Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med. 2005;11(7):791–6. Epub 2005/06/14. doi: 10.1038/nm1268 pmid:15951748; PubMed Central PMCID: PMC2918402.
[16]
Yi M, Villanueva RA, Thomas DL, Wakita T, Lemon SM. Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc Natl Acad Sci U S A. 2006;103(7):2310–5. Epub 2006/02/08. doi: 10.1073/pnas.0510727103 pmid:16461899; PubMed Central PMCID: PMC1413728.
[17]
Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A. 2005;102(26):9294–9. Epub 2005/06/09. doi: 10.1073/pnas.0503596102 pmid:15939869; PubMed Central PMCID: PMC1166622.
[18]
Merz A, Long G, Hiet MS, Brugger B, Chlanda P, Andre P, et al. Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome. J Biol Chem. 2011;286(4):3018–32. Epub 2010/11/09. doi: 10.1074/jbc.M110.175018 pmid:21056986; PubMed Central PMCID: PMC3024796.
[19]
Lindenbach BD. Virion assembly and release. Current topics in microbiology and immunology. 2013;369:199–218. Epub 2013/03/07. doi: 10.1007/978-3-642-27340-7_8 pmid:23463202; PubMed Central PMCID: PMC3925669.
[20]
Klein KC, Polyak SJ, Lingappa JR. Unique features of hepatitis C virus capsid formation revealed by de novo cell-free assembly. J Virol. 2004;78(17):9257–69. Epub 2004/08/17. doi: 10.1128/JVI.78.17.9257–9269.2004 pmid:15308720; PubMed Central PMCID: PMC506955.
[21]
Kunkel M, Lorinczi M, Rijnbrand R, Lemon SM, Watowich SJ. Self-assembly of nucleocapsid-like particles from recombinant hepatitis C virus core protein. J Virol. 2001;75(5):2119–29. Epub 2001/02/13. doi: 10.1128/JVI.75.5.2119–2129.2001 pmid:11160716; PubMed Central PMCID: PMC114796.
[22]
Matsumoto M, Hwang SB, Jeng KS, Zhu N, Lai MM. Homotypic interaction and multimerization of hepatitis C virus core protein. Virology. 1996;218(1):43–51. Epub 1996/04/01. doi: 10.1006/viro.1996.0164 pmid:8615040.
[23]
Moradpour D, Englert C, Wakita T, Wands JR. Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology. 1996;222(1):51–63. Epub 1996/08/01. doi: 10.1006/viro.1996.0397 pmid:8806487.
[24]
Barba G, Harper F, Harada T, Kohara M, Goulinet S, Matsuura Y, et al. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci U S A. 1997;94(4):1200–5. Epub 1997/02/18. pmid:9037030; PubMed Central PMCID: PMC19768. doi: 10.1073/pnas.94.4.1200
[25]
Boulant S, Vanbelle C, Ebel C, Penin F, Lavergne JP. Hepatitis C virus core protein is a dimeric alpha-helical protein exhibiting membrane protein features. J Virol. 2005;79(17):11353–65. Epub 2005/08/17. doi: 10.1128/JVI.79.17.11353–11365.2005 pmid:16103187; PubMed Central PMCID: PMC1193582.
[26]
Boulant S, Montserret R, Hope RG, Ratinier M, Targett-Adams P, Lavergne JP, et al. Structural determinants that target the hepatitis C virus core protein to lipid droplets. J Biol Chem. 2006;281(31):22236–47. Epub 2006/05/18. doi: 10.1074/jbc.M601031200 pmid:16704979.
[27]
Santolini E, Migliaccio G, La Monica N. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol. 1994;68(6):3631–41. Epub 1994/06/01. pmid:8189501; PubMed Central PMCID: PMC236867.
[28]
McLauchlan J, Lemberg MK, Hope G, Martoglio B. Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets. EMBO J. 2002;21(15):3980–8. Epub 2002/07/30. doi: 10.1093/emboj/cdf414 pmid:12145199; PubMed Central PMCID: PMC126158.
[29]
Targett-Adams P, Hope G, Boulant S, McLauchlan J. Maturation of hepatitis C virus core protein by signal peptide peptidase is required for virus production. J Biol Chem. 2008;283(24):16850–9. Epub 2008/04/22. doi: 10.1074/jbc.M802273200 pmid:18424431.
[30]
Appel N, Zayas M, Miller S, Krijnse-Locker J, Schaller T, Friebe P, et al. Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog. 2008;4(3):e1000035. Epub 2008/03/29. doi: 10.1371/journal.ppat.1000035 pmid:18369481; PubMed Central PMCID: PMC2268006.
[31]
Masaki T, Suzuki R, Murakami K, Aizaki H, Ishii K, Murayama A, et al. Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles. J Virol. 2008;82(16):7964–76. Epub 2008/06/06. doi: 10.1128/JVI.00826-08 pmid:18524832; PubMed Central PMCID: PMC2519576.
[32]
Love RA, Brodsky O, Hickey MJ, Wells PA, Cronin CN. Crystal structure of a novel dimeric form of NS5A domain I protein from hepatitis C virus. J Virol. 2009;83(9):4395–403. Epub 2009/02/27. doi: 10.1128/JVI.02352-08 pmid:19244328; PubMed Central PMCID: PMC2668466.
[33]
Tellinghuisen TL, Marcotrigiano J, Rice CM. Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase. Nature. 2005;435(7040):374–9. Epub 2005/05/20. doi: 10.1038/nature03580 pmid:15902263; PubMed Central PMCID: PMC1440517.
[34]
Brass V, Bieck E, Montserret R, Wolk B, Hellings JA, Blum HE, et al. An amino-terminal amphipathic alpha-helix mediates membrane association of the hepatitis C virus nonstructural protein 5A. J Biol Chem. 2002;277(10):8130–9. Epub 2001/12/18. doi: 10.1074/jbc.M111289200 pmid:11744739.
[35]
Tellinghuisen TL, Marcotrigiano J, Gorbalenya AE, Rice CM. The NS5A protein of hepatitis C virus is a zinc metalloprotein. J Biol Chem. 2004;279(47):48576–87. Epub 2004/09/02. doi: 10.1074/jbc.M407787200 pmid:15339921.
[36]
Hanoulle X, Verdegem D, Badillo A, Wieruszeski JM, Penin F, Lippens G. Domain 3 of non-structural protein 5A from hepatitis C virus is natively unfolded. Biochem Biophys Res Commun. 2009;381(4):634–8. Epub 2009/03/03. doi: 10.1016/j.bbrc.2009.02.108 pmid:19249289.
[37]
Liang Y, Ye H, Kang CB, Yoon HS. Domain 2 of nonstructural protein 5A (NS5A) of hepatitis C virus is natively unfolded. Biochemistry. 2007;46(41):11550–8. Epub 2007/09/21. doi: 10.1021/bi700776e pmid:17880107.
[38]
Huang L, Hwang J, Sharma SD, Hargittai MR, Chen Y, Arnold JJ, et al. Hepatitis C virus nonstructural protein 5A (NS5A) is an RNA-binding protein. J Biol Chem. 2005;280(43):36417–28. Epub 2005/08/30. doi: 10.1074/jbc.M508175200 pmid:16126720.
[39]
Foster TL, Belyaeva T, Stonehouse NJ, Pearson AR, Harris M. All three domains of the hepatitis C virus nonstructural NS5A protein contribute to RNA binding. J Virol. 2010;84(18):9267–77. Epub 2010/07/02. doi: 10.1128/JVI.00616-10 pmid:20592076; PubMed Central PMCID: PMC2937630.
[40]
Tellinghuisen TL, Foss KL, Treadaway J. Regulation of hepatitis C virion production via phosphorylation of the NS5A protein. PLoS Pathog. 2008;4(3):e1000032. Epub 2008/03/29. doi: 10.1371/journal.ppat.1000032 pmid:18369478; PubMed Central PMCID: PMC2265800.
[41]
Yi M, Lemon SM. Adaptive mutations producing efficient replication of genotype 1a hepatitis C virus RNA in normal Huh7 cells. J Virol. 2004;78(15):7904–15. Epub 2004/07/16. doi: 10.1128/JVI.78.15.7904–7915.2004 pmid:15254163; PubMed Central PMCID: PMC446091.
[42]
Gentzsch J, Brohm C, Steinmann E, Friesland M, Menzel N, Vieyres G, et al. hepatitis c Virus p7 is critical for capsid assembly and envelopment. PLoS Pathog. 2013;9(5):e1003355. Epub 2013/05/10. doi: 10.1371/journal.ppat.1003355 pmid:23658526; PubMed Central PMCID: PMC3642076.
[43]
Shavinskaya A, Boulant S, Penin F, McLauchlan J, Bartenschlager R. The lipid droplet binding domain of hepatitis C virus core protein is a major determinant for efficient virus assembly. J Biol Chem. 2007;282(51):37158–69. Epub 2007/10/19. doi: 10.1074/jbc.M707329200 pmid:17942391.
[44]
Alsaleh K, Delavalle PY, Pillez A, Duverlie G, Descamps V, Rouille Y, et al. Identification of basic amino acids at the N-terminal end of the core protein that are crucial for hepatitis C virus infectivity. J Virol. 2010;84(24):12515–28. Epub 2010/10/15. doi: 10.1128/JVI.01393-10 pmid:20943968; PubMed Central PMCID: PMC3004332.
[45]
Liu S, Ansari IH, Das SC, Pattnaik AK. Insertion and deletion analyses identify regions of non-structural protein 5A of Hepatitis C virus that are dispensable for viral genome replication. J Gen Virol. 2006;87(Pt 2):323–7. Epub 2006/01/25. doi: 10.1099/vir.0.81407–0 pmid:16432018.
[46]
Reiss S, Rebhan I, Backes P, Romero-Brey I, Erfle H, Matula P, et al. Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. Cell Host Microbe. 2011;9(1):32–45. Epub 2011/01/18. doi: 10.1016/j.chom.2010.12.002 pmid:21238945; PubMed Central PMCID: PMC3433060.
[47]
Jirasko V, Montserret R, Lee JY, Gouttenoire J, Moradpour D, Penin F, et al. Structural and functional studies of nonstructural protein 2 of the hepatitis C virus reveal its key role as organizer of virion assembly. PLoS Pathog. 2010;6(12):e1001233. Epub 2010/12/29. doi: 10.1371/journal.ppat.1001233 pmid:21187906; PubMed Central PMCID: PMC3002993.
[48]
Benga WJ, Krieger SE, Dimitrova M, Zeisel MB, Parnot M, Lupberger J, et al. Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles. Hepatology. 2010;51(1):43–53. Epub 2009/12/17. doi: 10.1002/hep.23278 pmid:20014138.
[49]
Cun W, Jiang J, Luo G. The C-terminal alpha-helix domain of apolipoprotein E is required for interaction with nonstructural protein 5A and assembly of hepatitis C virus. J Virol. 2010;84(21):11532–41. Epub 2010/08/20. doi: 10.1128/JVI.01021-10 pmid:20719944; PubMed Central PMCID: PMC2953147.
[50]
Evans MJ, Rice CM, Goff SP. Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication. Proc Natl Acad Sci U S A. 2004;101(35):13038–43. Epub 2004/08/25. doi: 10.1073/pnas.0405152101 pmid:15326295; PubMed Central PMCID: PMC516513.
[51]
Jiang J, Luo G. Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles. J Virol. 2009;83(24):12680–91. Epub 2009/10/02. doi: 10.1128/JVI.01476-09 pmid:19793818; PubMed Central PMCID: PMC2786834.
[52]
Lee JY, Acosta EG, Stoeck IK, Long G, Hiet MS, Mueller B, et al. Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteins. J Virol. 2014;88(21):12422–37. Epub 2014/08/15. doi: 10.1128/JVI.01660-14 pmid:25122793; PubMed Central PMCID: PMC4248909.
[53]
Backes P, Quinkert D, Reiss S, Binder M, Zayas M, Rescher U, et al. Role of annexin A2 in the production of infectious hepatitis C virus particles. J Virol. 2010;84(11):5775–89. Epub 2010/03/26. doi: 10.1128/JVI.02343-09 pmid:20335258; PubMed Central PMCID: PMC2876593.
[54]
Shi ST, Polyak SJ, Tu H, Taylor DR, Gretch DR, Lai MM. Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. Virology. 2002;292(2):198–210. Epub 2002/03/07. doi: 10.1006/viro.2001.1225 pmid:11878923.
[55]
Catanese MT, Uryu K, Kopp M, Edwards TJ, Andrus L, Rice WJ, et al. Ultrastructural analysis of hepatitis C virus particles. Proc Natl Acad Sci U S A. 2013;110(23):9505–10. Epub 2013/05/22. doi: 10.1073/pnas.1307527110 pmid:23690609; PubMed Central PMCID: PMC3677472.
[56]
Meunier JC, Russell RS, Engle RE, Faulk KN, Purcell RH, Emerson SU. Apolipoprotein c1 association with hepatitis C virus. J Virol. 2008;82(19):9647–56. Epub 2008/08/01. doi: 10.1128/JVI.00914-08 pmid:18667498; PubMed Central PMCID: PMC2546963.
[57]
Chang KS, Jiang J, Cai Z, Luo G. Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture. J Virol. 2007;81(24):13783–93. Epub 2007/10/05. doi: 10.1128/JVI.01091-07 pmid:17913825; PubMed Central PMCID: PMC2168882.
[58]
Nielsen SU, Bassendine MF, Burt AD, Martin C, Pumeechockchai W, Toms GL. Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. J Virol. 2006;80(5):2418–28. Epub 2006/02/14. doi: 10.1128/JVI.80.5.2418–2428.2006 pmid:16474148; PubMed Central PMCID: PMC1395398.
[59]
Lo SY, Selby MJ, Ou JH. Interaction between hepatitis C virus core protein and E1 envelope protein. J Virol. 1996;70(8):5177–82. Epub 1996/08/01. pmid:8764026; PubMed Central PMCID: PMC190473.
[60]
Ma HC, Ke CH, Hsieh TY, Lo SY. The first hydrophobic domain of the hepatitis C virus E1 protein is important for interaction with the capsid protein. J Gen Virol. 2002;83(Pt 12):3085–92. Epub 2002/12/06. pmid:12466485. doi: 10.1099/0022-1317-83-12-3085
[61]
Nakai K, Okamoto T, Kimura-Someya T, Ishii K, Lim CK, Tani H, et al. Oligomerization of hepatitis C virus core protein is crucial for interaction with the cytoplasmic domain of E1 envelope protein. J Virol. 2006;80(22):11265–73. Epub 2006/09/15. doi: 10.1128/JVI.01203-06 pmid:16971440; PubMed Central PMCID: PMC1642162.
[62]
Migliaccio CT, Follis KE, Matsuura Y, Nunberg JH. Evidence for a polytopic form of the E1 envelope glycoprotein of Hepatitis C virus. Virus research. 2004;105(1):47–57. Epub 2004/08/25. doi: 10.1016/j.virusres.2004.04.013 pmid:15325080.
[63]
Vieyres G, Thomas X, Descamps V, Duverlie G, Patel AH, Dubuisson J. Characterization of the envelope glycoproteins associated with infectious hepatitis C virus. J Virol. 2010;84(19):10159–68. Epub 2010/07/30. doi: 10.1128/JVI.01180-10 pmid:20668082; PubMed Central PMCID: PMC2937754.
[64]
Berger C, Romero-Brey I, Radujkovic D, Terreux R, Zayas M, Paul D, et al. Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication. Gastroenterology. 2014;147(5):1094–105 e25. Epub 2014/07/22. doi: 10.1053/j.gastro.2014.07.019 pmid:25046163.
[65]
McGivern DR, Masaki T, Williford S, Ingravallo P, Feng Z, Lahser F, et al. Kinetic analyses reveal potent and early blockade of hepatitis C virus assembly by NS5A inhibitors. Gastroenterology. 2014;147(2):453–62 e7. Epub 2014/04/29. doi: 10.1053/j.gastro.2014.04.021 pmid:24768676; PubMed Central PMCID: PMC4107048.
[66]
Guedj J, Dahari H, Rong L, Sansone ND, Nettles RE, Cotler SJ, et al. Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life. Proc Natl Acad Sci U S A. 2013;110(10):3991–6. Epub 2013/02/23. doi: 10.1073/pnas.1203110110 pmid:23431163; PubMed Central PMCID: PMC3593898.
[67]
Schaller T, Appel N, Koutsoudakis G, Kallis S, Lohmann V, Pietschmann T, et al. Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes. J Virol. 2007;81(9):4591–603. Epub 2007/02/16. doi: 10.1128/JVI.02144-06 pmid:17301154; PubMed Central PMCID: PMC1900174.
[68]
Counihan NA, Rawlinson SM, Lindenbach BD. Trafficking of hepatitis C virus core protein during virus particle assembly. PLoS Pathog. 2011;7(10):e1002302. Epub 2011/10/27. doi: 10.1371/journal.ppat.1002302 pmid:22028650; PubMed Central PMCID: PMC3197604.
[69]
Yanagi M, Purcell RH, Emerson SU, Bukh J. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci U S A. 1997;94(16):8738–43. Epub 1997/08/05. pmid:9238047; PubMed Central PMCID: PMC23104. doi: 10.1073/pnas.94.16.8738
[70]
Koch JO, Bartenschlager R. Modulation of hepatitis C virus NS5A hyperphosphorylation by nonstructural proteins NS3, NS4A, and NS4B. J Virol. 1999;73(9):7138–46. Epub 1999/08/10. pmid:10438800; PubMed Central PMCID: PMC104237.
[71]
Owsianka A, Tarr AW, Juttla VS, Lavillette D, Bartosch B, Cosset FL, et al. Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein. J Virol. 2005;79(17):11095–104. Epub 2005/08/17. doi: 10.1128/JVI.79.17.11095–11104.2005 pmid:16103160; PubMed Central PMCID: PMC1193588.
[72]
Friebe P, Boudet J, Simorre JP, Bartenschlager R. Kissing-loop interaction in the 3' end of the hepatitis C virus genome essential for RNA replication. J Virol. 2005;79(1):380–92. Epub 2004/12/15. doi: 10.1128/JVI.79.1.380–392.2005 pmid:15596831; PubMed Central PMCID: PMC538730.
[73]
Binder M, Kochs G, Bartenschlager R, Lohmann V. Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy. Hepatology. 2007;46(5):1365–74. Epub 2007/08/03. doi: 10.1002/hep.21829 pmid:17668876.
[74]
Blight KJ, McKeating JA, Rice CM. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol. 2002;76(24):13001–14. Epub 2002/11/20. pmid:12438626; PubMed Central PMCID: PMC136668. doi: 10.1128/jvi.76.24.13001-13014.2002
[75]
Krieger N, Lohmann V, Bartenschlager R. Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J Virol. 2001;75(10):4614–24. Epub 2001/04/20. doi: 10.1128/JVI.75.10.4614–4624.2001 pmid:11312331; PubMed Central PMCID: PMC114214.
[76]
Gastaminza P, Kapadia SB, Chisari FV. Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles. J Virol. 2006;80(22):11074–81. Epub 2006/09/08. doi: 10.1128/JVI.01150-06 pmid:16956946; PubMed Central PMCID: PMC1642172.
[77]
Bolte S, Cordelieres FP. A guided tour into subcellular colocalization analysis in light microscopy. Journal of microscopy. 2006;224(Pt 3):213–32. Epub 2007/01/11. doi: 10.1111/j.1365-2818.2006.01706.x pmid:17210054.
[78]
Phan T, Beran RK, Peters C, Lorenz IC, Lindenbach BD. Hepatitis C virus NS2 protein contributes to virus particle assembly via opposing epistatic interactions with the E1-E2 glycoprotein and NS3-NS4A enzyme complexes. J Virol. 2009;83(17):8379–95. Epub 2009/06/12. doi: 10.1128/JVI.00891-09 pmid:19515772; PubMed Central PMCID: PMC2738163.